Dr Reddy's accused of making false claims about financials, shares slump 7%
US-based law firm Lundin Law, which specialises in securities litigations is investigating claims against Dr Reddy's Laboratories for possible violations of federal security laws, which the drug maker has denied.
Nov 19, 2015, 14:30 PM IST
Dr Reddy's continues to see huge selling, down over 5%
The stock has fallen by over 20 percent in three days.
Nov 10, 2015, 13:14 PM IST
Dr Reddy's launches generic Paricalcitol capsules in US market
Drug firm Dr Reddy's Laboratories has launched generic Paricalcitol capsules used for treating secondary hyperparathyroidism associated with chronic kidney disease in the American market, following approval by the US health regulator.
Jun 25, 2014, 13:32 PM IST
